23andMe SPAC Presentation Deck
Pharmaceutical Industry
7
years average
time-to-IND¹
~90%
failure rate²
>>
23andMe
~4
years
for our
CD96 drug
2X
increase in
probability of
success³
NATURE PUBLICATION
The support of human genetic evidence
for approved drug indications
Nelson et. al 2015
IND = Investigational New Drug Application. fdareview.org, "The Drug Development and Approval Process" (2020).
2 Probability of success for a drug to be approved is estimated to be <12%. PhRMA, "Biopharmaceutical Research & Development:
The Process Behind New Medicines" (2015).
3 Nature Publication, "The support of human genetic evidence for approved drug indications" (2015).
23andMe Can
Efficiently Develop
Novel Therapeutics
by Power, Need
and Speed
23andMe Confidential and Proprietary Information 22View entire presentation